Founded by Luis M. Alvarez, whose work grew from questions raised by combat injuries, Frederick-based Theradaptive develops protein-engineering technologies for targeted tissue regeneration. Its platform creates material-binding protein variants that coat implants and carriers, including AMP2, an engineered BMP-2 variant now being evaluated in investigational spinal-fusion and dental bone-regeneration products. The company’s work spans vascular, soft-tissue, orthopedic and targeted therapeutic delivery applications.